rxstat › Classes › Antithrombotic Agents
Antithrombotic Agents: shortage status in Canada
10 of the 25 antithrombotic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageRivaroxaban5 of 18 reported products affected · est. return Nov 30, 2026Partial shortageTiclopidine1 of 1 reported products affectedPartial shortageTinzaparin1 of 11 reported products affected · est. return Jun 6, 2026Partial shortageWarfarin4 of 23 reported products affected · est. return Aug 7, 2026Shortage anticipatedHeparin0 of 11 reported products affectedDiscontinuedAbciximab0 of 1 reported products affectedDiscontinuedAcenocoumarol0 of 2 reported products affectedDiscontinuedAcetylsalicylic Acid Dipyridamole0 of 2 reported products affectedNo current shortageAlteplaseNo current shortageApixabanNo current shortageArgatrobanNo current shortageDipyridamoleNo current shortageEnoxaparinNo current shortageEpoprostenolDiscontinuedEptifibatide0 of 4 reported products affectedNo current shortageHeparin DextroseNo current shortageHeparin Dibasic Citric Acid DextroseDiscontinuedRivaroxaban Rivaroxaban0 of 1 reported products affectedNo current shortageWater Alteplase
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.